BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025

  June 17, 2025

   · 

  1 min read
• Press Releases

  Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025

  June 17, 2025

   · 

  2 min read
• Press Releases

  Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases

  June 17, 2025

   · 

  6 min read
• Press Releases

  Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

  June 17, 2025

   · 

  7 min read
• Press Releases

  U.S. Food and Drug Administration Approves CSL’s ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All Patients From the Start

  June 17, 2025

   · 

  9 min read
• Press Releases

  Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational Progress

  June 17, 2025

   · 

  11 min read
• Press Releases

  Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion

  June 17, 2025

   · 

  3 min read
• Press Releases

  Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

  June 17, 2025

   · 

  2 min read
• Press Releases

  Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease

  June 17, 2025

   · 

  5 min read
• Press Releases

  AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes

  June 17, 2025

   · 

  10 min read